Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.
Identifieur interne : 001027 ( Main/Exploration ); précédent : 001026; suivant : 001028Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.
Auteurs : D. Daily [Israël] ; A. Vlamis-Gardikas ; D. Offen ; L. Mittelman ; E. Melamed ; A. Holmgren ; A. BarzilaiSource :
- The Journal of biological chemistry [ 0021-9258 ] ; 2001.
Descripteurs français
- KwdFr :
- Activation enzymatique (MeSH), Animaux (MeSH), Animaux nouveau-nés (MeSH), Antienzymes (pharmacologie), Apoptose (effets des médicaments et des substances chimiques), Cellules cultivées (MeSH), Cervelet (cytologie), Cervelet (physiologie), Dopamine (pharmacologie), Escherichia coli (MeSH), Facteur de transcription NF-kappa B (métabolisme), Farnésol (analogues et dérivés), Farnésol (pharmacologie), Glutarédoxines (MeSH), JNK Mitogen-Activated Protein Kinases (MeSH), Mitogen-Activated Protein Kinases (métabolisme), Modèles neurologiques (MeSH), Neurones (cytologie), Neurones (effets des médicaments et des substances chimiques), Neurones (physiologie), Oxidoreductases (MeSH), Phosphatidylinositol 3-kinases (métabolisme), Phosphorylation (MeSH), Protein-Serine-Threonine Kinases (MeSH), Protéines (pharmacologie), Protéines G ras (métabolisme), Protéines bactériennes (pharmacologie), Protéines proto-oncogènes (métabolisme), Protéines proto-oncogènes c-akt (MeSH), Salicylates (pharmacologie), Souris (MeSH), Souris de lignée BALB C (MeSH), Système de signalisation des MAP kinases (effets des médicaments et des substances chimiques), Système de signalisation des MAP kinases (physiologie).
- MESH :
- analogues et dérivés : Farnésol.
- cytologie : Cervelet, Neurones.
- effets des médicaments et des substances chimiques : Apoptose, Neurones, Système de signalisation des MAP kinases.
- métabolisme : Facteur de transcription NF-kappa B, Mitogen-Activated Protein Kinases, Phosphatidylinositol 3-kinases, Protéines G ras, Protéines proto-oncogènes.
- pharmacologie : Antienzymes, Dopamine, Farnésol, Protéines, Protéines bactériennes, Salicylates.
- physiologie : Cervelet, Neurones, Système de signalisation des MAP kinases.
- Activation enzymatique, Animaux, Animaux nouveau-nés, Cellules cultivées, Escherichia coli, Glutarédoxines, JNK Mitogen-Activated Protein Kinases, Modèles neurologiques, Oxidoreductases, Phosphorylation, Protein-Serine-Threonine Kinases, Protéines proto-oncogènes c-akt, Souris, Souris de lignée BALB C.
English descriptors
- KwdEn :
- Animals (MeSH), Animals, Newborn (MeSH), Apoptosis (drug effects), Bacterial Proteins (pharmacology), Cells, Cultured (MeSH), Cerebellum (cytology), Cerebellum (physiology), Dopamine (pharmacology), Enzyme Activation (MeSH), Enzyme Inhibitors (pharmacology), Escherichia coli (MeSH), Farnesol (analogs & derivatives), Farnesol (pharmacology), Glutaredoxins (MeSH), JNK Mitogen-Activated Protein Kinases (MeSH), MAP Kinase Signaling System (drug effects), MAP Kinase Signaling System (physiology), Mice (MeSH), Mice, Inbred BALB C (MeSH), Mitogen-Activated Protein Kinases (metabolism), Models, Neurological (MeSH), NF-kappa B (metabolism), Neurons (cytology), Neurons (drug effects), Neurons (physiology), Oxidoreductases (MeSH), Phosphatidylinositol 3-Kinases (metabolism), Phosphorylation (MeSH), Protein-Serine-Threonine Kinases (MeSH), Proteins (pharmacology), Proto-Oncogene Proteins (metabolism), Proto-Oncogene Proteins c-akt (MeSH), Salicylates (pharmacology), ras Proteins (metabolism).
- MESH :
- chemical , analogs & derivatives : Farnesol.
- chemical , metabolism : Mitogen-Activated Protein Kinases, NF-kappa B, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins, ras Proteins.
- chemical , pharmacology : Bacterial Proteins, Dopamine, Enzyme Inhibitors, Farnesol, Proteins, Salicylates.
- cytology : Cerebellum, Neurons.
- drug effects : Apoptosis, MAP Kinase Signaling System, Neurons.
- physiology : Cerebellum, MAP Kinase Signaling System, Neurons.
- Animals, Animals, Newborn, Cells, Cultured, Enzyme Activation, Escherichia coli, Glutaredoxins, JNK Mitogen-Activated Protein Kinases, Mice, Mice, Inbred BALB C, Models, Neurological, Oxidoreductases, Phosphorylation, Protein-Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt.
Abstract
Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1). An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.
DOI: 10.1074/jbc.M101400200
PubMed: 11290748
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.</title>
<author><name sortKey="Daily, D" sort="Daily, D" uniqKey="Daily D" first="D" last="Daily">D. Daily</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978</wicri:regionArea>
<wicri:noRegion>Tel Aviv 69978</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vlamis Gardikas, A" sort="Vlamis Gardikas, A" uniqKey="Vlamis Gardikas A" first="A" last="Vlamis-Gardikas">A. Vlamis-Gardikas</name>
</author>
<author><name sortKey="Offen, D" sort="Offen, D" uniqKey="Offen D" first="D" last="Offen">D. Offen</name>
</author>
<author><name sortKey="Mittelman, L" sort="Mittelman, L" uniqKey="Mittelman L" first="L" last="Mittelman">L. Mittelman</name>
</author>
<author><name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author><name sortKey="Holmgren, A" sort="Holmgren, A" uniqKey="Holmgren A" first="A" last="Holmgren">A. Holmgren</name>
</author>
<author><name sortKey="Barzilai, A" sort="Barzilai, A" uniqKey="Barzilai A" first="A" last="Barzilai">A. Barzilai</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2001">2001</date>
<idno type="RBID">pubmed:11290748</idno>
<idno type="pmid">11290748</idno>
<idno type="doi">10.1074/jbc.M101400200</idno>
<idno type="wicri:Area/Main/Corpus">001032</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001032</idno>
<idno type="wicri:Area/Main/Curation">001032</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001032</idno>
<idno type="wicri:Area/Main/Exploration">001032</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.</title>
<author><name sortKey="Daily, D" sort="Daily, D" uniqKey="Daily D" first="D" last="Daily">D. Daily</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</nlm:affiliation>
<country xml:lang="fr">Israël</country>
<wicri:regionArea>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978</wicri:regionArea>
<wicri:noRegion>Tel Aviv 69978</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Vlamis Gardikas, A" sort="Vlamis Gardikas, A" uniqKey="Vlamis Gardikas A" first="A" last="Vlamis-Gardikas">A. Vlamis-Gardikas</name>
</author>
<author><name sortKey="Offen, D" sort="Offen, D" uniqKey="Offen D" first="D" last="Offen">D. Offen</name>
</author>
<author><name sortKey="Mittelman, L" sort="Mittelman, L" uniqKey="Mittelman L" first="L" last="Mittelman">L. Mittelman</name>
</author>
<author><name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
</author>
<author><name sortKey="Holmgren, A" sort="Holmgren, A" uniqKey="Holmgren A" first="A" last="Holmgren">A. Holmgren</name>
</author>
<author><name sortKey="Barzilai, A" sort="Barzilai, A" uniqKey="Barzilai A" first="A" last="Barzilai">A. Barzilai</name>
</author>
</analytic>
<series><title level="j">The Journal of biological chemistry</title>
<idno type="ISSN">0021-9258</idno>
<imprint><date when="2001" type="published">2001</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term>
<term>Animals, Newborn (MeSH)</term>
<term>Apoptosis (drug effects)</term>
<term>Bacterial Proteins (pharmacology)</term>
<term>Cells, Cultured (MeSH)</term>
<term>Cerebellum (cytology)</term>
<term>Cerebellum (physiology)</term>
<term>Dopamine (pharmacology)</term>
<term>Enzyme Activation (MeSH)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Escherichia coli (MeSH)</term>
<term>Farnesol (analogs & derivatives)</term>
<term>Farnesol (pharmacology)</term>
<term>Glutaredoxins (MeSH)</term>
<term>JNK Mitogen-Activated Protein Kinases (MeSH)</term>
<term>MAP Kinase Signaling System (drug effects)</term>
<term>MAP Kinase Signaling System (physiology)</term>
<term>Mice (MeSH)</term>
<term>Mice, Inbred BALB C (MeSH)</term>
<term>Mitogen-Activated Protein Kinases (metabolism)</term>
<term>Models, Neurological (MeSH)</term>
<term>NF-kappa B (metabolism)</term>
<term>Neurons (cytology)</term>
<term>Neurons (drug effects)</term>
<term>Neurons (physiology)</term>
<term>Oxidoreductases (MeSH)</term>
<term>Phosphatidylinositol 3-Kinases (metabolism)</term>
<term>Phosphorylation (MeSH)</term>
<term>Protein-Serine-Threonine Kinases (MeSH)</term>
<term>Proteins (pharmacology)</term>
<term>Proto-Oncogene Proteins (metabolism)</term>
<term>Proto-Oncogene Proteins c-akt (MeSH)</term>
<term>Salicylates (pharmacology)</term>
<term>ras Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Activation enzymatique (MeSH)</term>
<term>Animaux (MeSH)</term>
<term>Animaux nouveau-nés (MeSH)</term>
<term>Antienzymes (pharmacologie)</term>
<term>Apoptose (effets des médicaments et des substances chimiques)</term>
<term>Cellules cultivées (MeSH)</term>
<term>Cervelet (cytologie)</term>
<term>Cervelet (physiologie)</term>
<term>Dopamine (pharmacologie)</term>
<term>Escherichia coli (MeSH)</term>
<term>Facteur de transcription NF-kappa B (métabolisme)</term>
<term>Farnésol (analogues et dérivés)</term>
<term>Farnésol (pharmacologie)</term>
<term>Glutarédoxines (MeSH)</term>
<term>JNK Mitogen-Activated Protein Kinases (MeSH)</term>
<term>Mitogen-Activated Protein Kinases (métabolisme)</term>
<term>Modèles neurologiques (MeSH)</term>
<term>Neurones (cytologie)</term>
<term>Neurones (effets des médicaments et des substances chimiques)</term>
<term>Neurones (physiologie)</term>
<term>Oxidoreductases (MeSH)</term>
<term>Phosphatidylinositol 3-kinases (métabolisme)</term>
<term>Phosphorylation (MeSH)</term>
<term>Protein-Serine-Threonine Kinases (MeSH)</term>
<term>Protéines (pharmacologie)</term>
<term>Protéines G ras (métabolisme)</term>
<term>Protéines bactériennes (pharmacologie)</term>
<term>Protéines proto-oncogènes (métabolisme)</term>
<term>Protéines proto-oncogènes c-akt (MeSH)</term>
<term>Salicylates (pharmacologie)</term>
<term>Souris (MeSH)</term>
<term>Souris de lignée BALB C (MeSH)</term>
<term>Système de signalisation des MAP kinases (effets des médicaments et des substances chimiques)</term>
<term>Système de signalisation des MAP kinases (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Farnesol</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Mitogen-Activated Protein Kinases</term>
<term>NF-kappa B</term>
<term>Phosphatidylinositol 3-Kinases</term>
<term>Proto-Oncogene Proteins</term>
<term>ras Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Bacterial Proteins</term>
<term>Dopamine</term>
<term>Enzyme Inhibitors</term>
<term>Farnesol</term>
<term>Proteins</term>
<term>Salicylates</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>Farnésol</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Cervelet</term>
<term>Neurones</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Cerebellum</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Apoptosis</term>
<term>MAP Kinase Signaling System</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Apoptose</term>
<term>Neurones</term>
<term>Système de signalisation des MAP kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Facteur de transcription NF-kappa B</term>
<term>Mitogen-Activated Protein Kinases</term>
<term>Phosphatidylinositol 3-kinases</term>
<term>Protéines G ras</term>
<term>Protéines proto-oncogènes</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antienzymes</term>
<term>Dopamine</term>
<term>Farnésol</term>
<term>Protéines</term>
<term>Protéines bactériennes</term>
<term>Salicylates</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Cervelet</term>
<term>Neurones</term>
<term>Système de signalisation des MAP kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Cerebellum</term>
<term>MAP Kinase Signaling System</term>
<term>Neurons</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Animals, Newborn</term>
<term>Cells, Cultured</term>
<term>Enzyme Activation</term>
<term>Escherichia coli</term>
<term>Glutaredoxins</term>
<term>JNK Mitogen-Activated Protein Kinases</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Models, Neurological</term>
<term>Oxidoreductases</term>
<term>Phosphorylation</term>
<term>Protein-Serine-Threonine Kinases</term>
<term>Proto-Oncogene Proteins c-akt</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Activation enzymatique</term>
<term>Animaux</term>
<term>Animaux nouveau-nés</term>
<term>Cellules cultivées</term>
<term>Escherichia coli</term>
<term>Glutarédoxines</term>
<term>JNK Mitogen-Activated Protein Kinases</term>
<term>Modèles neurologiques</term>
<term>Oxidoreductases</term>
<term>Phosphorylation</term>
<term>Protein-Serine-Threonine Kinases</term>
<term>Protéines proto-oncogènes c-akt</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1). An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11290748</PMID>
<DateCompleted><Year>2001</Year>
<Month>07</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0021-9258</ISSN>
<JournalIssue CitedMedium="Print"><Volume>276</Volume>
<Issue>24</Issue>
<PubDate><Year>2001</Year>
<Month>Jun</Month>
<Day>15</Day>
</PubDate>
</JournalIssue>
<Title>The Journal of biological chemistry</Title>
<ISOAbbreviation>J Biol Chem</ISOAbbreviation>
</Journal>
<ArticleTitle>Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways.</ArticleTitle>
<Pagination><MedlinePgn>21618-26</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Glutaredoxin 2 (Grx2) from Escherichia coli protects cerebellar neurons from dopamine-induced apoptosis via nuclear factor kappa B (NF-kappaB) activation, which is mediated by the expression of redox factor-1 (Ref-1). An analysis of the mechanisms underlying Grx2 protective activity revealed dual activation of signal transduction pathways. Grx2 significantly activated the Ras/phosphoinositide 3-kinase/Akt/NF-kappaB cascade in parallel to the Jun N-terminal kinase (JNK)/AP1 cascade. Dopamine, in comparison, down-regulated both pathways. Treatment of neurons with Ref-1 antisense oligonucleotide reduced the ability of Grx2 to activate Akt and AP-1 but had no effect on the phosphorylation of JNK1/2, suggesting that Akt/NF-kappaB and AP-1 are regulated by Ref-1. Exposure of the neurons to JNK1/2 antisense oligonucleotide in the presence of Grx2 significantly reduced AP-1 and NF-kappaB DNA binding activities and abolished Grx2 protection. These results demonstrate that dual activation of Ras/phosphoinositide 3-kinase and AP-1 cascades, which are mediated by Ref-1, is an essential component of the Grx2 mechanism of action.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daily</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vlamis-Gardikas</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Offen</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mittelman</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Melamed</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
<Author ValidYN="Y"><LastName>Holmgren</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Barzilai</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2001</Year>
<Month>04</Month>
<Day>04</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>J Biol Chem</MedlineTA>
<NlmUniqueID>2985121R</NlmUniqueID>
<ISSNLinking>0021-9258</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C516009">Glrx2 protein, mouse</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D054477">Glutaredoxins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011506">Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011518">Proto-Oncogene Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012459">Salicylates</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C093323">farnesylthiosalicylic acid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4602-84-0</RegistryNumber>
<NameOfSubstance UI="D005204">Farnesol</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 1.-</RegistryNumber>
<NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.1.-</RegistryNumber>
<NameOfSubstance UI="D019869">Phosphatidylinositol 3-Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D017346">Protein-Serine-Threonine Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber>
<NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048031">JNK Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D020928">Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.6.5.2</RegistryNumber>
<NameOfSubstance UI="D018631">ras Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber>
<NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002531" MajorTopicYN="N">Cerebellum</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="Y">cytology</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005204" MajorTopicYN="N">Farnesol</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D054477" MajorTopicYN="N">Glutaredoxins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D048031" MajorTopicYN="N">JNK Mitogen-Activated Protein Kinases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020928" MajorTopicYN="N">Mitogen-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008959" MajorTopicYN="N">Models, Neurological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010088" MajorTopicYN="Y">Oxidoreductases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019869" MajorTopicYN="N">Phosphatidylinositol 3-Kinases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010766" MajorTopicYN="N">Phosphorylation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017346" MajorTopicYN="Y">Protein-Serine-Threonine Kinases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011518" MajorTopicYN="N">Proto-Oncogene Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012459" MajorTopicYN="N">Salicylates</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018631" MajorTopicYN="N">ras Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2001</Year>
<Month>7</Month>
<Day>20</Day>
<Hour>10</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2001</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>10</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">11290748</ArticleId>
<ArticleId IdType="doi">10.1074/jbc.M101400200</ArticleId>
<ArticleId IdType="pii">M101400200</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Israël</li>
</country>
</list>
<tree><noCountry><name sortKey="Barzilai, A" sort="Barzilai, A" uniqKey="Barzilai A" first="A" last="Barzilai">A. Barzilai</name>
<name sortKey="Holmgren, A" sort="Holmgren, A" uniqKey="Holmgren A" first="A" last="Holmgren">A. Holmgren</name>
<name sortKey="Melamed, E" sort="Melamed, E" uniqKey="Melamed E" first="E" last="Melamed">E. Melamed</name>
<name sortKey="Mittelman, L" sort="Mittelman, L" uniqKey="Mittelman L" first="L" last="Mittelman">L. Mittelman</name>
<name sortKey="Offen, D" sort="Offen, D" uniqKey="Offen D" first="D" last="Offen">D. Offen</name>
<name sortKey="Vlamis Gardikas, A" sort="Vlamis Gardikas, A" uniqKey="Vlamis Gardikas A" first="A" last="Vlamis-Gardikas">A. Vlamis-Gardikas</name>
</noCountry>
<country name="Israël"><noRegion><name sortKey="Daily, D" sort="Daily, D" uniqKey="Daily D" first="D" last="Daily">D. Daily</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/GlutaredoxinV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001027 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001027 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= GlutaredoxinV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:11290748 |texte= Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the ras-phosphoinositide 3-kinase and jun n-terminal kinase pathways. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:11290748" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a GlutaredoxinV1
This area was generated with Dilib version V0.6.37. |